Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-09-15

FDA Approved: GLUCAGON — Original Application (Cipla USA Inc.)

View source ↗

Summary

The FDA approved Cipla USA Inc.'s original application for a generic glucagon product, enabling its marketing to treat severe hypoglycemia in people with diabet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GLUCAGON (GLUCAGON)

Snippet

ORIG AP for GLUCAGON (GLUCAGON)